help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmidt, H. H.-J.
Right arrow Articles by Brabant, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, H. H.-J.
Right arrow Articles by Brabant, G.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*OMIM
*UniGene
*Substance via MeSH
*Genetics Home Reference
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 5 2289-2295
Copyright © 2001 by The Endocrine Society


Original Studies

Dyslipemia in Familial Partial Lipodystrophy Caused by an R482W Mutation in the LMNA Gene

Hartmut H.-J. Schmidt, Janine Genschel, Peter Baier, Martina Schmidt, Johann Ockenga, Uwe J. F. Tietge, Marcus Pröpsting, Carsten Büttner, Michael P. Manns, Herbert Lochs and Georg Brabant

Charité Campus Mitte, Medizinische Klinik Gastroenterologie, Hepatologie und Endokrinologie (H.H.-J.S., J.G., P.B., M.P., C.B., H.L.), 10098 Berlin, Germany; Abteilung Klinische Endokrinologie (M.S., G.B.) und Abteilung Gastroenterologie und Hepatologie (J.O., U.J.F.T., M.P.M.), Medizinische Hochschule Hannover, 30623 Hannover, Germany

Address all correspondence and requests for reprints to: Dr. Hartmut Schmidt, Med. Klinik Gastroenterologie, Hepatologie, und Endokrinologie, Humboldt Universität, Charité Campus Mitte, 10098 Berlin, Germany. E-mail: hartmut.schmidt{at}charite.de

Lipatrophic diabetes, also referred to as familial partial lipodystrophy, is a rare disease that is metabolically characterized by hypertriglyceridemia and insulin resistance. Affected patients typically present with regional loss of body fat and muscular hypertrophic appearance. Variable symptoms may comprise pancreatitis and/or eruptive xanthomas due to severe hypertriglyceridemia, acanthosis nigricans, polycystic ovaria, and carpal tunnel syndrome. Mutations within the LMNA gene on chromosome 1q21.2 were recently reported to result in the phenotype of familial partial lipodystrophy. The genetic trait is autosomal dominant. We identified a family with partial lipodystrophy carrying the R482W (Arg482Trp) missense mutation within LMNA. Here we present the lipoprotein characteristics in this family in detail. Clinically, the loss of sc fat and muscular hypertrophy especially of the lower extremities started as early as in childhood. Acanthosis and severe hypertriglyceridemia developed later in life, followed by diabetes. The characterization of the lipoprotein subfractions revealed that affected children present with hyperlipidemia. The presence and severity of hyperlipidemia seem to be influenced by age, apolipoprotein E genotype, and the coexistence of diabetes mellitus. In conclusion, dyslipemia is an early and prominent feature in the presented lipodystrophic family carrying the R482W mutation within LMNA.




This article has been cited by other articles:


Home page
J. Med. Genet.Home page
A. Ludtke, J. Buettner, H. H-J Schmidt, and H. J Worman
New PPARG mutation leads to lipodystrophy and loss of protein function that is partially restored by a synthetic ligand
J. Med. Genet., September 1, 2007; 44(9): e88 - e88.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Ludtke, J. Buettner, W. Wu, A. Muchir, A. Schroeter, S. Zinn-Justin, S. Spuler, H. H.-J. Schmidt, and H. J. Worman
Peroxisome Proliferator-Activated Receptor-{gamma} C190S Mutation Causes Partial Lipodystrophy
J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2248 - 2255.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. Spuler, T. Kalbhenn, J. Zabojszcza, F.K.H. van Landeghem, A. Ludtke, K. Wenzel, M. Koehnlein, M. Schuelke, L. Ludemann, and H. H. Schmidt
Muscle and nerve pathology in Dunnigan familial partial lipodystrophy
Neurology, February 27, 2007; 68(9): 677 - 683.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. Lemieux
Energy Partitioning in Gluteal-Femoral Fat: Does the Metabolic Fate of Triglycerides Affect Coronary Heart Disease Risk?
Arterioscler. Thromb. Vasc. Biol., May 1, 2004; 24(5): 795 - 797.
[Full Text]


Home page
Diabetes CareHome page
K. L. Herbst, L. R. Tannock, S. S. Deeb, J. Q. Purnell, J. D. Brunzell, and A. Chait
Kobberling Type of Familial Partial Lipodystrophy: An underrecognized syndrome
Diabetes Care, June 1, 2003; 26(6): 1819 - 1824.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. H.-J. Schmidt and R. A. Hegele
Consider Cardiomyopathy in Subjects With Familial Partial Lipodystrophy Response
Circulation, January 15, 2002; 105 (2): e7 - e7.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society